The University of Chicago Header Logo

Connection

John Fung to Immunoconjugates

This is a "connection" page, showing publications John Fung has written about Immunoconjugates.
Connection Strength

0.435
  1. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
    View in: PubMed
    Score: 0.051
  2. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
    View in: PubMed
    Score: 0.048
  3. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation. 2001 Oct 27; 72(8 Suppl):S13-22.
    View in: PubMed
    Score: 0.048
  4. Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):604.
    View in: PubMed
    Score: 0.046
  5. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
    View in: PubMed
    Score: 0.044
  6. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
    View in: PubMed
    Score: 0.040
  7. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
    View in: PubMed
    Score: 0.040
  8. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
    View in: PubMed
    Score: 0.040
  9. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
    View in: PubMed
    Score: 0.040
  10. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.